Masimo Corporation (LON:0JZ2)
152.08
+5.31 (3.62%)
Jan 22, 2026, 8:56 AM GMT
Masimo Market Cap
Masimo has a market cap or net worth of 5.73 billion as of January 22, 2026. Its market cap has decreased by -22.42% in one year.
Market Cap
5.73B
Enterprise Value
5.93B
Revenue
1.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
152.08
Market Cap Chart
Since August 8, 2007, Masimo's market cap has increased from 541.95M to 5.73B, an increase of 957.21%. That is a compound annual growth rate of 13.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 5.85B | 12.62% |
| Dec 31, 2025 | 5.19B | -26.58% |
| Dec 31, 2024 | 7.07B | 45.39% |
| Dec 29, 2023 | 4.86B | -24.67% |
| Dec 30, 2022 | 6.45B | -45.94% |
| Dec 31, 2021 | 11.94B | 10.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.86B |
| GSK plc | 71.72B |
| Haleon | 33.21B |
| Smith & Nephew | 10.20B |
| Convatec Group | 4.51B |
| Hikma Pharmaceuticals | 3.37B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.87B |